Verastem (VSTM) Change in Account Payables (2011 - 2026)
Verastem's (VSTM) quarterly Change in Account Payables came in at -$2.8 million in Q1 2026, down 189.69% year-on-year from $3.2 million in Q1 2025, and down 172.9% quarter-over-quarter from $3.9 million in Q4 2025.
Verastem (VSTM) Change in Account Payables (2011 - 2026) Analysis & Trends
Verastem's Change in Account Payables history runs 16 years deep, the most recent figure standing at -$2.8 million for Q1 2026.
- On a quarterly basis, Change in Account Payables fell 189.69% year-over-year to -$2.8 million in Q1 2026; TTM through Mar 2026 was $2.4 million, a 1061.2% increase from a year earlier, with the FY2025 full-year figure at $8.4 million, up 366.69% from the prior year.
- Change in Account Payables slipped to -$2.8 million in Q1 2026 per VSTM's latest filing, from $3.9 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $3.9 million in Q4 2025 and bottomed at -$2.8 million in Q1 2026.
- The 5-year median for Change in Account Payables is $92000.0 (2022), against an average of $429411.8.
- Biggest YoY gain for Change in Account Payables was 13150.0% in 2024; the steepest drop was 450.55% in 2024.
- Year by year, Change in Account Payables stood at -$458000.0 in 2022, then surged by 551.09% to $2.1 million in 2023, then tumbled by 119.94% to -$412000.0 in 2024, then jumped by 1047.57% to $3.9 million in 2025, then tumbled by 172.9% to -$2.8 million in 2026.
- Per Business Quant, the three latest VSTM Change in Account Payables figures stand at -$2.8 million (Q1 2026), $3.9 million (Q4 2025), and $497000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn | -2.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.85 Mn |
| Mar 31, 2026 | -2.85 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Sep 30, 2025 | 497,000.00 |
| Sep 30, 2025 | 497,000.00 |
| Jun 30, 2025 | 848,000.00 |
| Jun 30, 2025 | 848,000.00 |
| Mar 31, 2025 | 3.17 Mn |
| Mar 31, 2025 | 3.17 Mn |
| Dec 31, 2024 | -412,000.00 |
| Dec 31, 2024 | -412,000.00 |
| Sep 30, 2024 | -2.24 Mn |
| Sep 30, 2024 | -2.24 Mn |
| Jun 30, 2024 | -771,000.00 |
| Jun 30, 2024 | -771,000.00 |
| Mar 31, 2024 | 265,000.00 |
| Mar 31, 2024 | 265,000.00 |
| Dec 31, 2023 | 2.07 Mn |
| Dec 31, 2023 | 2.07 Mn |